Clathrin-Mediated Endocytosis for Enhanced Apoptosis Induction and Cellular Imaging in Triple-Negative Breast Cancer by Casein-Protected Blue-Emissive Carbon Dots
- 6 September 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 8 (10) , 9042-9057
Abstract
The development of multifunctional nanoplatforms capable of drug delivery and real-time cellular imaging remains a key challenge in cancer theranostics. Herein, we report the development of a casein-protected maleic acid-derived nitrogen-doped carbon dot-based luminescent nanoplatform (MNCD@Cas NPs) for efficient delivery of the anticancer drug doxorubicin hydrochloride (DOX) to triple-negative breast cancer cells. Synthesized via a facile two-step method, the MNCD@Cas NPs exhibit bright blue fluorescence (λem = 390 nm), high water dispersibility, excellent colloidal stability, and substantial DOX loading capacity (∼84%) driven by electrostatic interactions. The drug-loaded MNCD@Cas NPs (DOX@MNCD@Cas NPs) exhibited clathrin-mediated endocytosis in MDA-MB-231 cells and pH-dependent drug release at higher levels under mild acidic conditions. Clathrin-mediated endocytosis was validated by confocal microscopic imaging of early endosomal antigen 1 expression, which showed a significant reduction in red fluorescent vesicles upon pretreatment with monodansyl cadaverine, a clathrin-mediated endocytosis inhibitor, compared to nystatin, an inhibitor of caveolin-mediated uptake. Further, the flow-cytometry-based quantification of DOX fluorescence confirmed the reduced intracellular uptake in MDC-pretreated cells, supporting the predominant involvement of clathrin-mediated internalization. The system induced pronounced cell cycle arrest at sub-G1 and G2-M phases, indicating apoptosis induction, as evident by confocal microscopy imaging and flow cytometric analysis. The intrinsic fluorescence of a biocompatible carbon dot enables real-time cellular imaging without using any external dye. This dual functionality such as anticancer drug delivery and imaging capability positions DOX-loaded MNCD@Cas NPs as a highly promising nanotheranostic platform.Keywords
This publication has 66 references indexed in Scilit:
- A comparative evaluation of anti-tumor activity following oral and intravenous delivery of doxorubicin in a xenograft model of breast tumorJournal of Pharmaceutical Investigation, 2022
- A composite consisting of bromine-doped carbon dots and ferric ions as a fluorescent probe for determination and intracellular imaging of phosphateMicrochimica Acta, 2019
- A simple and sensitive fluorescent sensor for methyl parathion based on l -tyrosine methyl ester functionalized carbon dotsBiosensors and Bioelectronics, 2015
- Facile synthesis of N, S-codoped fluorescent carbon nanodots for fluorescent resonance energy transfer recognition of methotrexate with high sensitivity and selectivityBiosensors and Bioelectronics, 2015
- Selective Detection of Ferric Ions by Blue–Green Photoluminescent Nitrogen‐Doped Phenol Formaldehyde Resin PolymerSmall, 2014
- Simple and Green Synthesis of Nitrogen‐Doped Photoluminescent Carbonaceous Nanospheres for BioimagingAngewandte Chemie, 2013
- Prodrug-based intracellular delivery of anticancer agentsAdvanced Drug Delivery Reviews, 2011
- Blue Photoluminescence from Chemically Derived Graphene OxideAdvanced Materials, 2010
- Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticlesInternational Journal of Cancer, 2007
- Estimation of an optimal radiotherapy utilization rate for melanomaCancer, 2004